hexstone capital

Not found
Recent contents
  1. Propanc Biopharma Raises $100M Crypto Fund to Advance Cancer Treatment

    Propanc Biopharma Raises $100M Crypto Fund to Advance Cancer Treatment

    Propanc Biopharma Raises $100M Crypto Fund to Advance Cancer Treatment Australian biotech firm Propanc Biopharma has secured up to $100 million in funding from Hexstone Capital to establish a cryptocurrency-backed fund dedicated to advancing enzyme-based cancer therapies. The deal marks a rare...
  • This site uses cookies to help personalise content, tailor your experience and to keep you logged in if you register.
    By continuing to use this site, you are consenting to our use of cookies.
    Accept Learn more…
Back
Top